|
Originally published In Press as doi:10.1074/jbc.M005399200 on August 22, 2000
J. Biol. Chem., Vol. 275, Issue 45, 35328-35334, November 10, 2000
An Oncogenic Epidermal Growth Factor Receptor Signals via a
p21-activated Kinase-Caldesmon-Myosin Phosphotyrosine Complex*
Michael J.
McManus §,
Julie L.
Boerner¶,
Andrew J.
Danielsen ,
Ze
Wang ,
Fumio
Matsumura , and
Nita J.
Maihle **
From the Department of Biochemistry and Molecular
Biology and the ¶ Tumor Biology Program, Mayo Clinic,
Rochester, Minnesota 55905 and the Department of Molecular
Biology and Biochemistry, Nelson Laboratories, Rutgers
University/Busch Campus, Piscataway, New Jersey 08854
Many ligand-independent receptor tyrosine kinases
are tumorigenic. The biochemical signals that mediate
ligand-independent transformation of cells by these transmembrane
receptors are poorly defined. In this report, we demonstrate that a
constitutively activated mutant epidermal growth factor receptor
(v-ErbB) induces the formation of a transformation-specific signaling
module that complexes with myosin II. The components of this signaling
complex include the signal adapter proteins Shc, Grb2, and Nck, and
tyrosine-phosphorylated forms of p21-activated kinase (Pak), caldesmon,
and myosin light chain kinase. Transformation-specific, tyrosine
phosphorylation of Pak enhances the catalytic activity of this
serine/threonine kinase. Furthermore, the tyrosine phosphorylation of
Pak is Rho-, but not Ras-, Rac-, or Cdc42-dependent. These
results demonstrate that a ligand-independent epidermal growth factor
receptor mutant can transduce oncogenic signals that are distinct from
ligand-dependent, mitogenic signals. In addition, these
data provide evidence for the coupling of oncogenic receptor tyrosine
kinases with the actomyosin molecular motor. This myosin-associated
signaling module may mediate some of the biochemical changes of myosin
found in v-ErbB- transformed fibroblasts, thereby contributing to the
regulation of the mechanical forces governing cellular adhesion,
cytoskeletal tension, and, hence, anchorage-independent cell growth.
*
This work was supported by National Institutes of Health
Grants CA75238, CA79808, and CA75926 and American Heart Association Grant 97-30163N.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Current address: Dept. of Molecular and Experimental Medicine,
Scripps Research Inst., La Jolla, CA 92037.
**
To whom correspondence should be addressed: Mayo Clinic, 200 First
St. S.W., Rochester, MN 55905. Tel.: 507-284-8121; E-mail: maihle@mayo.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Rider, A. Shatrova, E. P. Feener, L. Webb, and M. Diakonova
JAK2 Tyrosine Kinase Phosphorylates PAK1 and Regulates PAK1 Activity and Functions
J. Biol. Chem.,
October 19, 2007;
282(42):
30985 - 30996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Yang, R. K. Vadlamudi, and R. Kumar
Dynein Light Chain 1 Phosphorylation Controls Macropinocytosis
J. Biol. Chem.,
January 7, 2005;
280(1):
654 - 659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Lu, Z.-Z. Pan, Y. Devaux, and P. Ray
p21-activated Protein Kinase 4 (PAK4) Interacts with the Keratinocyte Growth Factor Receptor and Participates in Keratinocyte Growth Factor-mediated Inhibition of Oxidant-induced Cell Death
J. Biol. Chem.,
March 14, 2003;
278(12):
10374 - 10380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. H. Renkema, K. Pulkkinen, and K. Saksela
Cdc42/Rac1-Mediated Activation Primes PAK2 for Superactivation by Tyrosine Phosphorylation
Mol. Cell. Biol.,
October 1, 2002;
22(19):
6719 - 6725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Boerner, A. Danielsen, M. J. McManus, and N. J. Maihle
Activation of Rho Is Required for Ligand-independent Oncogenic Signaling by a Mutant Epidermal Growth Factor Receptor
J. Biol. Chem.,
January 26, 2001;
276(5):
3691 - 3695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Kamm and J. T. Stull
Dedicated Myosin Light Chain Kinases with Diverse Cellular Functions
J. Biol. Chem.,
February 9, 2001;
276(7):
4527 - 4530.
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|